Discover how leveraging TLR7/8 agonists in combination with systemic IFN-I represents a promising strategy for treating melanoma.

Scientists have discovered a novel subset of cancer-fighting immune cells that reside outside of their normal neighborhood -- known as the tertiary lymphoid structure -- where they become ...

The authors focused on glioma, a cancer known for its resistance to immunotherapy, its high heterogeneity (not all tumour cells have the same mutations in individual tumours and different ...

Scientists have discovered a novel subset of cancer-fighting immune cells that reside outside of their normal neighborhood – ...

Researchers have discovered and analyzed a rare but serious side effect of an innovative form of blood cancer therapy. The ...

What factors influence the success or failure of immunotherapy treatment in patients with advanced bladder cancer? Why do ...

Immunotherapy, which uses programmed immune cells to selectively destroy cancer cells, has transformed cancer treatment.

Researchers have discovered and analysed a rare but serious side effect of an innovative form of blood cancer therapy. The scientists from the University of Leipzig Medical Center, the Fraunhofer ...

近年来，运动医学发展迅速，其研究内容已从传统的运动创伤防治、运动康复、以及运动促进健康与慢性疾病防治等领域，进一步拓展到了癌症治疗领域，成为精准医学中不可或缺的重要组成部分。

Cancer immunotherapy works by programming immune cells to recognize and eliminate cancer cells. However, many cancers can escape immune surveillance through various mechanisms, resulting in ...

Photoimmunotherapy is an innovative cancer treatment that combines phototherapy with immunotherapy to selectively target and ...

Triple-negative breast cancer (TNBC) is an aggressive form of the disease that accounts for 15% of all breast cancer cases.